ArticleOncoTargets and therapy2022

Clinical Response to Neoadjuvant Immunotherapy Combined with Targeted Therapy and Chemotherapy in Oral Squamous Cell Carcinoma: Experience in Three Patients.

Yu Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.